UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Current treatment of antiphospholipid syndrome: lights and shadows

Nature reviews. Rheumatology, 2015-10, Vol.11 (10), p.586

2015

Link zum Volltext

Verfügbarkeit prüfen

The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study

Arthritis research & therapy, 2022-01, Vol.24 (1), p.9-9, Article 9

2022

Link zum Volltext

Verfügbarkeit prüfen

Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center

Arthritis research & therapy, 2022-04, Vol.24 (1), p.91-91, Article 91

2022

Link zum Volltext

Verfügbarkeit prüfen

Catastrophic antiphospholipid syndrome: an update

Panminerva medica, 2017-09, Vol.59 (3), p.254

2017

Link zum Volltext

Verfügbarkeit prüfen

Relapsing Catastrophic Antiphospholipid Syndrome Potential Role of Microangiopathic Hemolytic Anemia in Disease Relapses

Seminars in arthritis and rheumatism, 2013-02, Vol.42 (4), p.417-423

2013

Link zum Volltext

Verfügbarkeit prüfen

Relapsing Catastrophic Antiphospholipid Syndrome: Report of Three Cases

Seminars in arthritis and rheumatism, 2008-06, Vol.37 (6), p.366-372

2008

Link zum Volltext

Verfügbarkeit prüfen

Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels

Thrombosis and haemostasis, 2009-02, Vol.101 (2), p.312

2009

Link zum Volltext

Verfügbarkeit prüfen

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”

Autoimmunity reviews, 2022-04, Vol.21 (4), p.103055, Article 103055

2022

Link zum Volltext

Verfügbarkeit prüfen

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1011-1018

2015

Link zum Volltext

Verfügbarkeit prüfen

Amputation of Digits or Limbs in Patients with Antiphospholipid Syndrome

Seminars in arthritis and rheumatism, 2008-10, Vol.38 (2), p.124-131

2008

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary involvement in catastrophic antiphospholipid syndrome: A descriptive analysis from the “CAPS Registry”

Seminars in arthritis and rheumatism, 2023-12, Vol.63, p.152265-152265, Article 152265

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the “CAPS registry”

Seminars in arthritis and rheumatism, 2024-06, Vol.66, p.152439-152439, Article 152439

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review

Medicina clinica, 2015-02, Vol.144 (3), p.97

2015

Link zum Volltext

Verfügbarkeit prüfen

Intestinal Involvement Secondary to the Antiphospholipid Syndrome (APS): Clinical and Immunologic Characteristics of 97 Patients: Comparison of Classic and Catastrophic APS

Seminars in arthritis and rheumatism, 2007-04, Vol.36 (5), p.287-296

2007

Link zum Volltext

Verfügbarkeit prüfen

Catastrophic APS in the Context of Other Thrombotic Microangiopathies

Current rheumatology reports, 2015, Vol.17 (1), p.482-482, Article 3

2015

Link zum Volltext

Verfügbarkeit prüfen

Correlation of placental lesions in patients with systemic lupus erythematosus, antiphospholipid syndrome and non-criteria obstetric antiphospholipid syndrome and adverse perinatal outcomes

Placenta (Eastbourne), 2023-08, Vol.139, p.92-98

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center

Lupus, 2020-08, Vol.29 (9), p.1050-1059

2020

Link zum Volltext

Verfügbarkeit prüfen

Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group

Placenta (Eastbourne), 2023-05, Vol.136, p.29-34

2023

Link zum Volltext

Verfügbarkeit prüfen

Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative

Immunologic research, 2013-07, Vol.56 (2-3), p.358-361

2013

Link zum Volltext

Verfügbarkeit prüfen

Catastrophic antiphospholipid syndrome and sepsis. A common link?

Journal of rheumatology, 2007-05, Vol.34 (5), p.923

2007

Link zum Volltext

Verfügbarkeit prüfen

Thromboprophylaxis and obstetric management of the antiphospholipid syndrome

Expert opinion on pharmacotherapy, 2009-03, Vol.10 (4), p.601-614

2009

Link zum Volltext

Verfügbarkeit prüfen

The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients with antiphospholipid syndrome

Thrombosis research, 2018-09, Vol.169, p.128-134

2018

Link zum Volltext

Verfügbarkeit prüfen

Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus

Journal of thrombosis and thrombolysis, 2021-07, Vol.52 (1), p.30-41

2021

Link zum Volltext

Verfügbarkeit prüfen

Antiphospholipid syndrome

Arthritis research & therapy, 2008-01, Vol.10 (6), p.230-230

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

ThemaAntiphospholipid Syndrome - Complications

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(32)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(40)
Life Sciences & Biomedicine
(39)
Science & Technology
(39)
Female
(33)
Adult
(25)
Male
(22)
Antiphospholipid Syndrome
(21)
Middle Aged
(21)
Pregnancy
(20)
Rheumatology
(20)
Antiphospholipid Antibodies
(14)
Anticoagulants - Therapeutic Use
(11)
Lupus Erythematosus, Systemic - Complications
(11)
Thrombosis
(11)
Biological And Medical Sciences
(10)
Thrombosis - Etiology
(10)
Aged
(9)
Antiphospholipid Syndrome - Diagnosis
(9)
Catastrophic Illness
(9)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current treatment of antiphospholipid syndrome: lights and shadows

The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study

Systemic sclerosis and pregnancy outcomes: a retrospective study from a single center

Catastrophic antiphospholipid syndrome: an update

Relapsing Catastrophic Antiphospholipid Syndrome Potential Role of Microangiopathic Hemolytic Anemia in Disease Relapses

Relapsing Catastrophic Antiphospholipid Syndrome: Report of Three Cases

Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels

Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry”

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

Amputation of Digits or Limbs in Patients with Antiphospholipid Syndrome

Pulmonary involvement in catastrophic antiphospholipid syndrome: A descriptive analysis from the “CAPS Registry”

Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the “CAPS registry”

Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review

Intestinal Involvement Secondary to the Antiphospholipid Syndrome (APS): Clinical and Immunologic Characteristics of 97 Patients: Comparison of Classic and Catastrophic APS

Catastrophic APS in the Context of Other Thrombotic Microangiopathies

Correlation of placental lesions in patients with systemic lupus erythematosus, antiphospholipid syndrome and non-criteria obstetric antiphospholipid syndrome and adverse perinatal outcomes

Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center

Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group

Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS)

Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative

Catastrophic antiphospholipid syndrome and sepsis. A common link?

Thromboprophylaxis and obstetric management of the antiphospholipid syndrome

The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients with antiphospholipid syndrome

Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus

Antiphospholipid syndrome

Aktive Filter

Suchergebnisse filtern